# OnCo record os-151 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/os-151/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "os-151" ;
  schema:name "OS-151"@en ;
  schema:alternateName "rBCG-STING"@en ;
  schema:description "OS-151 is an experimental modified BCG from OncoSTING for bladder cancer, built to release an immune-activating molecule. It is in laboratory testing."@en ;
  schema:url <https://onco.cc/drugs/os-151/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.oncosting.com/technology>, <https://reporter.nih.gov/project-details/11312959> ;
  onco:status "preclinical" ;
  onco:tag "pipeline" ;
  onco:modality "Recombinant BCG immunotherapy" ;
  onco:technologies <https://onco.cc/technologies/sting-agonist/> ;
  onco:companies <https://onco.cc/companies/oncosting/> .